Cardiology E, COMMITTEE P, Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, COMMITTEE S, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM , Linderbaum JA, Morrow DA, Newby L, Ornato JP, Ou N, Radford MJ, TamisHolland J, Tommaso CL, Tracy CM, Woo Y, Zhao DX, MEMBERS A, Halperin JL, Levine GN, Anderson JL, Albert NM, AlKhatib S, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Kovacs RJ, Ohman E, Pressler SJ, Sellke FW, Shen W, Wijeysundera DN
The successful tapering of psychotropic medications, without a return of symptoms, suggests that KMT may have played a central role in the stabilization and recovery of this patient
Phentermine is usually my first choice
Neuroprotective peptides preventing photoreceptor death before and after reattachment
Treatment Recommendations with Fumaric Acid Esters As a summary of treatment recommendations, it is advised to start with a low dose of a FAE then increase to the optimal dose by monitoring efficacy and side-effects
RM122.88 RM245.56 1
